• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用从基因型推算出的转录组开发机器学习模型以预测克罗恩病患者对抗肿瘤坏死因子治疗的非持久反应

Development of a Machine Learning Model to Predict Non-Durable Response to Anti-TNF Therapy in Crohn's Disease Using Transcriptome Imputed from Genotypes.

作者信息

Park Soo Kyung, Kim Yea Bean, Kim Sangsoo, Lee Chil Woo, Choi Chang Hwan, Kang Sang-Bum, Kim Tae Oh, Bang Ki Bae, Chun Jaeyoung, Cha Jae Myung, Im Jong Pil, Kim Min Suk, Ahn Kwang Sung, Kim Seon-Young, Park Dong Il

机构信息

Division of Gastroenterology, Department of Internal Medicine and Inflammatory Bowel Disease Center, Kangbuk Samsung Hospital, School of Medicine, Sungkyunkwan University, Seoul 03181, Korea.

Medical Research Institute, Kangbuk Samsung Hospital, School of Medicine, Sungkyunkwan University, Seoul 03181, Korea.

出版信息

J Pers Med. 2022 Jun 9;12(6):947. doi: 10.3390/jpm12060947.

DOI:10.3390/jpm12060947
PMID:35743732
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9224874/
Abstract

Almost half of patients show no primary or secondary response to monoclonal anti-tumor necrosis factor α (anti-TNF) antibody treatment for inflammatory bowel disease (IBD). Thus, the exact mechanisms of a non-durable response (NDR) remain inadequately defined. We used our genome-wide genotype data to impute expression values as features in training machine learning models to predict a NDR. Blood samples from various IBD cohorts were used for genotyping with the Korea Biobank Array. A total of 234 patients with Crohn's disease (CD) who received their first anti-TNF therapy were enrolled. The expression profiles of 6294 genes in whole-blood tissue imputed from the genotype data were combined with clinical parameters to train a logistic model to predict the NDR. The top two and three most significant features were genetic features (, , and ), not clinical features. The logistic regression of the NDR vs. DR status in our cohort by the imputed expression levels showed that the β coefficients were positive for and , and negative for , concordant with the known eQTL information. Machine learning models using imputed gene expression features effectively predicted NDR to anti-TNF agents in patients with CD.

摘要

近一半的患者对用于治疗炎症性肠病(IBD)的单克隆抗肿瘤坏死因子α(抗TNF)抗体治疗无原发性或继发性反应。因此,非持久反应(NDR)的确切机制仍未得到充分阐明。我们利用全基因组基因型数据推算表达值作为训练机器学习模型以预测NDR的特征。来自不同IBD队列的血样用于韩国生物样本库阵列基因分型。共纳入234例接受首次抗TNF治疗的克罗恩病(CD)患者。将从基因型数据推算出的全血组织中6294个基因的表达谱与临床参数相结合,训练一个逻辑模型以预测NDR。最显著的前两个和三个特征是遗传特征(、和),而非临床特征。根据推算的表达水平,对我们队列中NDR与持久反应(DR)状态进行逻辑回归分析,结果显示β系数对和为正,对为负,与已知的表达数量性状位点(eQTL)信息一致。利用推算的基因表达特征的机器学习模型可有效预测CD患者对抗TNF药物的NDR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e3/9224874/9d88f0cac6e5/jpm-12-00947-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e3/9224874/d4580c9859d0/jpm-12-00947-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e3/9224874/0e54945aac1a/jpm-12-00947-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e3/9224874/21ae74a05365/jpm-12-00947-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e3/9224874/9d88f0cac6e5/jpm-12-00947-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e3/9224874/d4580c9859d0/jpm-12-00947-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e3/9224874/0e54945aac1a/jpm-12-00947-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e3/9224874/21ae74a05365/jpm-12-00947-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50e3/9224874/9d88f0cac6e5/jpm-12-00947-g004.jpg

相似文献

1
Development of a Machine Learning Model to Predict Non-Durable Response to Anti-TNF Therapy in Crohn's Disease Using Transcriptome Imputed from Genotypes.利用从基因型推算出的转录组开发机器学习模型以预测克罗恩病患者对抗肿瘤坏死因子治疗的非持久反应
J Pers Med. 2022 Jun 9;12(6):947. doi: 10.3390/jpm12060947.
2
Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn's Disease.遗传标记可预测克罗恩病患者对抗TNF生物疗法的原发性无反应和持久反应。
Am J Gastroenterol. 2016 Dec;111(12):1816-1822. doi: 10.1038/ajg.2016.408. Epub 2016 Sep 6.
3
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
4
Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn's disease.基因多态性可预测克罗恩病患者对抗肿瘤坏死因子治疗的反应。
World J Gastroenterol. 2017 Jul 21;23(27):4958-4967. doi: 10.3748/wjg.v23.i27.4958.
5
[Anti-TNF therapy in treatment of luminal Crohn's disease].[抗TNF治疗在腔内型克罗恩病治疗中的应用]
Acta Med Croatica. 2013 Apr;67(2):179-89.
6
Landscape of sialylation patterns identify biomarkers for diagnosis and prediction of response to anti-TNF therapy in crohn's disease.唾液酸化模式图谱可识别用于克罗恩病抗TNF治疗反应诊断和预测的生物标志物。
Front Genet. 2022 Nov 14;13:1065297. doi: 10.3389/fgene.2022.1065297. eCollection 2022.
7
Multi-alleles predict primary non-response to infliximab therapy in Crohn's disease.多个等位基因可预测克罗恩病患者对英夫利昔单抗治疗的原发性无反应。
Gastroenterol Rep (Oxf). 2020 Dec 29;9(5):427-434. doi: 10.1093/gastro/goaa070. eCollection 2021 Oct.
8
Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.在难治性克罗恩病患儿中联合使用甲氨蝶呤和抗 TNF-α 治疗:病例系列研究。
Inflamm Bowel Dis. 2012 Aug;18(8):1488-92. doi: 10.1002/ibd.21885. Epub 2011 Aug 31.
9
Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease.炎症性肠病中肿瘤坏死因子-α和-β基因多态性的关联
J Inflamm Res. 2016 Jun 17;9:133-40. doi: 10.2147/JIR.S101225. eCollection 2016.
10
Metabonomics and the Gut Microbiome Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease.代谢组学和肠道微生物群与克罗恩病对 TNF 治疗的原发性反应相关。
J Crohns Colitis. 2020 Sep 7;14(8):1090-1102. doi: 10.1093/ecco-jcc/jjaa039.

引用本文的文献

1
Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease.数字生物标志物与人工智能:炎症性肠病个性化管理的新前沿。
Front Immunol. 2025 Aug 4;16:1637159. doi: 10.3389/fimmu.2025.1637159. eCollection 2025.
2
Artificial Intelligence in Advancing Inflammatory Bowel Disease Management: Setting New Standards.人工智能推动炎症性肠病管理:设定新标准。
Cancers (Basel). 2025 Jul 14;17(14):2337. doi: 10.3390/cancers17142337.
3
Artificial intelligence in inflammatory bowel disease: innovations in diagnosis, monitoring, and personalized care.

本文引用的文献

1
Development of a Machine Learning Model to Distinguish between Ulcerative Colitis and Crohn's Disease Using RNA Sequencing Data.利用RNA测序数据开发用于区分溃疡性结肠炎和克罗恩病的机器学习模型
Diagnostics (Basel). 2021 Dec 15;11(12):2365. doi: 10.3390/diagnostics11122365.
2
Expression Quantitative Trait Loci (eQTL) Mapping in Korean Patients With Crohn's Disease and Identification of Potential Causal Genes Through Integration With Disease Associations.韩国克罗恩病患者的表达定量性状基因座(eQTL)定位及通过与疾病关联整合鉴定潜在因果基因
Front Genet. 2020 May 14;11:486. doi: 10.3389/fgene.2020.00486. eCollection 2020.
3
炎症性肠病中的人工智能:诊断、监测及个性化医疗的创新进展
Therap Adv Gastroenterol. 2025 Jul 23;18:17562848251357407. doi: 10.1177/17562848251357407. eCollection 2025.
4
Evolution of inflammatory bowel disease in Korea: a 60-year perspective on clinical and research development.韩国炎症性肠病的演变:临床与研究发展的60年视角
Intest Res. 2025 Jul;23(3):233-253. doi: 10.5217/ir.2025.00073. Epub 2025 Jun 23.
5
Pharmacogenomics of TNF inhibitors.肿瘤坏死因子抑制剂的药物基因组学
Front Immunol. 2025 May 21;16:1521794. doi: 10.3389/fimmu.2025.1521794. eCollection 2025.
6
Early Progression Prediction in Korean Crohn's Disease Using a Korean-Specific PrediXcan Model.使用韩国特异性PrediXcan模型对韩国克罗恩病进行早期进展预测
Int J Mol Sci. 2025 Mar 23;26(7):2910. doi: 10.3390/ijms26072910.
7
Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review.人工智能将彻底改变炎症性肠病临床试验:全面综述。
Therap Adv Gastroenterol. 2025 Feb 23;18:17562848251321915. doi: 10.1177/17562848251321915. eCollection 2025.
8
Artificial intelligence use for precision medicine in inflammatory bowel disease: a systematic review.人工智能在炎症性肠病精准医学中的应用:一项系统综述。
Am J Transl Res. 2025 Jan 15;17(1):28-46. doi: 10.62347/XILL3707. eCollection 2025.
9
Multi-Omics Biomarkers for Predicting Efficacy of Biologic and Small-Molecule Therapies in Adults With Inflammatory Bowel Disease: A Systematic Review.用于预测生物制剂和小分子疗法对成人炎症性肠病疗效的多组学生物标志物:一项系统评价
United European Gastroenterol J. 2025 May;13(4):517-530. doi: 10.1002/ueg2.12720. Epub 2024 Dec 10.
10
Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion.人工智能对炎症性肠病患者预后、共同决策和精准医学的影响:观点和专家意见。
Ann Med. 2023;55(2):2300670. doi: 10.1080/07853890.2023.2300670. Epub 2024 Jan 1.
Glutathione S-transferase theta 1 protects against colitis through goblet cell differentiation via interleukin-22.
谷胱甘肽 S-转移酶 theta 1 通过白细胞介素-22 保护结肠通过杯状细胞分化。
FASEB J. 2020 Feb;34(2):3289-3304. doi: 10.1096/fj.201902421R. Epub 2020 Jan 9.
4
Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics.Wnt 信号在免疫细胞和癌症治疗中的调控作用。
Cells. 2019 Nov 3;8(11):1380. doi: 10.3390/cells8111380.
5
Accuracy of Gene Expression Prediction From Genotype Data With PrediXcan Varies Across and Within Continental Populations.使用PrediXcan从基因型数据预测基因表达的准确性在不同大陆人群之间和内部存在差异。
Front Genet. 2019 Apr 3;10:261. doi: 10.3389/fgene.2019.00261. eCollection 2019.
6
GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.GNAI1 和 GNAI3 通过阻断 IL6 信号和下调 GNAI2 的表达来减少小鼠的结肠炎相关肿瘤发生。
Gastroenterology. 2019 Jun;156(8):2297-2312. doi: 10.1053/j.gastro.2019.02.040. Epub 2019 Mar 2.
7
The Korea Biobank Array: Design and Identification of Coding Variants Associated with Blood Biochemical Traits.韩国生物银行阵列:与血液生化特征相关的编码变异的设计和鉴定。
Sci Rep. 2019 Feb 4;9(1):1382. doi: 10.1038/s41598-018-37832-9.
8
Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease.全血中低表达 TREM1 可预测炎症性肠病对 TNF 拮抗剂的反应。
EBioMedicine. 2019 Feb;40:733-742. doi: 10.1016/j.ebiom.2019.01.027. Epub 2019 Jan 24.
9
A One-Penny Imputed Genome from Next-Generation Reference Panels.基于新一代参考面板的单分钱估算基因组。
Am J Hum Genet. 2018 Sep 6;103(3):338-348. doi: 10.1016/j.ajhg.2018.07.015. Epub 2018 Aug 9.
10
TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?TREM-1,抗TNF治疗的克罗恩病患者内镜愈合的理想预测生物标志物?
Gut. 2019 Aug;68(8):1531-1533. doi: 10.1136/gutjnl-2018-316845. Epub 2018 Jul 14.